Elektrokonvulsionstherapie bei einer Patientin mit Kavernom in der Medulla oblongata

Zusammenfassung

Die Durchführung einer EKT-Behandlung sollte auch beim Vorliegen eines Kavernoms der Medulla oblongata mit früherer Blutung nicht grundsätzlich ausgeschlossen werden, erfordert aber entsprechende Voraussetzungen wie neurochirurgische Konsultation, ein striktes Blutdruckmonitoring und eine besondere Information des Patienten. Summary: Cavernous malformation in the medulla oblongata with previous bleeding is not in principle a reason for excluding electroconvulsive therapy. However, before such intervention is carried out, certain preconditions should be met such as neurosurgical consultation, close blood pressure monitoring and a special medical information of the patient.

Abstract

The implementation of ECT treatment should not be ruled out in principle even if there is a cavernoma of the medulla oblongata with previous bleeding, but it requires appropriate conditions such as neurosurgical consultation, strict blood pressure monitoring and special information from the patient.

Schlüsselwörter

Elektrokonvulsionstherapie - Kavernom - Depression

Key words

electroconvulsive therapy - cavernous malformation - depression

Publikationsverlauf

Eingereicht: 24. Februar 2020

Angenommen: 26. April 2020

Artikel online veröffentlicht:
13. Oktober 2020

• Literatur

• 1 Grözinger M, Conca A, Nickl-Jockschat T, Di Pauli J. ,Hrsg. Elektrokonvulsionstherapie kompakt. 1. Aufl. Heidelberg: Springer; 2013
• 2 Kang N, Passmore MJ. Successful ECT in a patient with an orbital cavernous hemangioma. JECT 2004; 20 (04) 267-271
• 3 Rasmussen KG, Flemming KD. Electroconvulsive therapy in patients with cavernous hemangiomas. JECT 2006; 22 (04) 272-273
• 4 Stewart JT, Long WG. Electroconvulsive therapy in a patient with a cavernous hemangioma. JECT 2008; 24 (04) 292
• 5 Salaris S, Szuba MP, Traber K. ECT and intracranial vascular masses. JECT 2000; 16 (02) 198-203
• 6 Malek-Ahmadi P, Hauret AT. Successful ECT in a patient with intracranial venous angioma. JECT 2002; 18 (02) 99-102
• 7 Beechar VB, Srinivasan MV, Reznik OE. et al. Ultraventricular cavernomas oft he third ventricle: report oft wo cases and a systematic review oft he literature. Supratentorial cavernous hemangiomas World Neurosurg 2017; 105: 935-943
• 8 Lin X, Meng G, Lin T. et al. The differentially expressed genes of human sporadic cerebral cavernous malformations. World Neurosurg 2018; 113: 247-279
• 9 Villalonga JF, Saenz A, Campero A. Surgical treatment of a symptomatic giant supratentorial cavernous hemangioma. Case Report: J Clin Neurosci 2019; 62: 231-234
• 10 Rosenow F, Alonso-Vanegas MA, Baumgartner C. et al. Cavernoma-related epilepsy: Review and recommandations for managment. Epilepsia 2013; 54 (12) 2025-2035
• 11 Blumberger DM, Seitz DP, Hermann N. et al. Low medical morbidity and mortality after acute courses of electrconvulsive therapy in population. Acta Psychiatr Scand 2017; 136 (06) 583-593
• 12 Xie MG, Li D, Guo FZ. et al. Brainstem cavernous malformations: Surgical indications based on natural history and surgical outcomes. World Neurosurg 2018; 110: 55-63